Hagar Kalinski
25Patents
8h-index
39Co-inventors
71Inventor score
Filing activity: May 25, 2006 → Apr 2, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8741867B2 | Retinoid-liposomes for treating fibrosis | Chemistry; Metallurgy | 31 | Active |
| US8664376B2 | Retinoid-liposomes for enhancing modulation of HSP47 expression | Chemistry; Metallurgy | 26 | Active |
| US9932578B2 | Double-stranded oligonucleotide molecules to P53 and methods of use thereof | Chemistry; Metallurgy | 24 | Active |
| US9121020B2 | Methods for treating eye disorders | Chemistry; Metallurgy | 21 | Active |
| US9206424B2 | Modulation of HSP47 expression | Chemistry; Metallurgy | 21 | Active |
| US8710209B2 | Modulation of HSP47 expression | Chemistry; Metallurgy | 20 | Active |
| US8614309B2 | Double-stranded RNA directed to CASP2 and methods of use thereof | Chemistry; Metallurgy | 10 | Active |
| US9456984B2 | Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier | Chemistry; Metallurgy | 10 | Active |
| US10093923B2 | Modulation of HSP47 expression | Chemistry; Metallurgy | 4 | Active |
| US10196637B2 | Retinoid-lipid drug carrier | Chemistry; Metallurgy | 3 | Active |
| US8278287B2 | siRNA compounds for inhibiting NRF2 | Chemistry; Metallurgy | 3 | Active |
| US9701961B2 | Methods for treating eye disorders | Chemistry; Metallurgy | 3 | Active |
| US9446062B2 | Methods of treating ischemia-reperfusion injury with siRNAs | Chemistry; Metallurgy | 2 | Active |
| US10195145B2 | Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier | Chemistry; Metallurgy | 2 | Active |
| US9611474B2 | Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US9205100B2 | Compositions and methods for treating lung disease and injury | Chemistry; Metallurgy | 1 | Active |
| US9822362B2 | Compositions and methods for treating lung disease and injury | Chemistry; Metallurgy | 1 | Active |
| US9487778B2 | Oligonucleotide modulators of the toll-like receptor pathway | Chemistry; Metallurgy | 1 | Active |
| US7524935B2 | Sequences characteristic of hypoxia-regulated gene transcription | Chemistry; Metallurgy | 0 | Expired |
| US8614311B2 | RTP801L siRNA compounds and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US9045755B2 | Double stranded RNA compounds to RhoA and use thereof | Chemistry; Metallurgy | 0 | Active |
| US8765931B2 | Double-stranded oligonucleotide compound for down-regulating the expression of CASP2 gene | Chemistry; Metallurgy | 0 | Active |
| US10781449B2 | Double-stranded oligonucleotide molecules targeting p53 and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US9796979B2 | Oligonucleotide modulators of the toll-like receptor pathway | Chemistry; Metallurgy | 0 | Active |
| US10421962B2 | Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.